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In Brief
PAR polarity pathway-mediated cell
polarization relies on a conserved
network of proteins including PAR-3,
CDC-42, PAR-6, and aPKC. Rodriguez,
Peglion et al. uncover a division of labor
whereby PAR-6 and aPKC cycle between
distinct cue-sensing and effector
assemblies that act cooperatively to
polarize the one-cell C. elegans zygote..
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The conserved polarity effector proteins PAR-3,
PAR-6, CDC-42, and atypical protein kinase C
(aPKC) form a core unit of the PAR protein network,
which plays a central role in polarizing a broad range
of animal cell types. To functionally polarize cells,
these proteins must activate aPKC within a spatially
defined membrane domain on one side of the cell
in response to symmetry-breaking cues. Using the
Caenorhabditis elegans zygote as a model, we find
that the localization and activation of aPKC involve
distinct, specialized aPKC-containing assemblies: a
PAR-3-dependent assembly that responds to polarity
cues and promotes efficient segregation of aPKC to-
ward the anterior but holds aPKC in an inactive state,
and a CDC-42-dependent assembly in which aPKC
is active but poorly segregated. Cycling of aPKC
between these distinct functional assemblies, which
appears to depend on aPKC activity, effectively
links cue-sensing and effector roles within the PAR
network to ensure robust establishment of polarity.
INTRODUCTION
A crucial step in the polarization of metazoan cells is the
localization of conserved sets of polarity effectors, known as
the partitioning-defective or PAR proteins, to discrete mem-
brane-associated cortical domains. Regulation of PAR protein
distribution is essential for the localized activation of signaling
pathways that coordinate many aspects of embryonic develop-
ment, including asymmetric cell division, epithelial organiza-
tion, and embryo axis establishment (Goldstein and Macara,
2007; St Johnston and Ahringer, 2010). Although the precise
details vary between systems, in most cases the conserved
PDZ domain proteins PAR-3 and PAR-6, the small guanosine
triphosphatase (GTPase) CDC-42 and atypical protein kinase400 Developmental Cell 42, 400–415, August 21, 2017 ª 2017 The A
This is an open access article under the CC BY license (http://creativeC (aPKC) act together to establish polarity on one side of the
cell and drive asymmetry of a range of downstream pathways
(reviewed in Goehring, 2014; McCaffrey and Macara, 2012; Su-
zuki et al., 2004; Ziomek et al., 1982).
In Caenorhabditis elegans, PAR-3, PAR-6, CDC-42, and the
aPKC ortholog, PKC-3, play an essential role in polarizing
the one-cell embryo or zygote by defining an anterior domain
and hence are referred to as anterior PARs or aPARs (Fig-
ures 1A–1C). An opposing set of posterior PARs or pPARs, con-
sisting of PAR-1, PAR-2, LGL-1, and the CDC-42 GAP, CHIN-1,
form a complementary domain at the posterior. Together,
aPARs and pPARs define the anterior-posterior axis of the
zygote and orchestrate an asymmetric division that restricts
germline determinants to the posterior daughter cell (Beatty
et al., 2010; Boyd et al., 1996; Etemad-Moghadam et al.,
1995; Gotta et al., 2001; Guo and Kemphues, 1995; Hoege
et al., 2010; Kay and Hunter, 2001; Kumfer et al., 2010; Tabuse
et al., 1998; Watts et al., 1996).
Polarization is triggered by the sperm-donated centrosome via
two semi-redundant pathways (Figures 1A and 1B). First, the
centrosome induces actomyosin cortical flow away from the
newly defined posterior pole, which transports membrane-asso-
ciated aPAR proteins into the anterior (Cheeks et al., 2004;
Goehring et al., 2011b; Mayer et al., 2010; Munro et al., 2004).
Second, centrosomal microtubules promote local loading of
PAR-2 in the posterior. PAR-2 then recruits PAR-1, which drives
posterior exclusion of aPARs through phosphorylation of PAR-3
(Boyd et al., 1996; Hao et al., 2006;Motegi et al., 2011). Following
this ‘‘establishment phase,’’ the zygote enters a ‘‘maintenance
phase’’ during which mutual antagonism between anterior and
posterior PARs ensures their continued asymmetric localizations
(Boyd et al., 1996; Cuenca et al., 2003; Etemad-Moghadam
et al., 1995; Guo and Kemphues, 1995; Tabuse et al., 1998;
Watts et al., 1996).
Anterior PAR protein function is mediated through the kinase
activity of PKC-3, which can phosphorylate PAR-1, PAR-2, and
LGL-1 and drive their dissociation from the membrane (Beatty
et al., 2010; Hao et al., 2006; Hoege et al., 2010; Hurov et al.,
2004; Motegi et al., 2011). PAR-3, PAR-6, and CDC-42 are all
required for proper PKC-3 membrane localization (Gotta et al.,uthor(s). Published by Elsevier Inc.
commons.org/licenses/by/4.0/).
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Figure 1. PKC-3 Kinase Inhibition Leads to Symmetric Division and Loss of Asymmetry of Downstream Polarity Markers
(A–C) Model for symmetry breaking by the PAR system inC. elegans. aPARs (red) initially occupy the membrane and pPARs (blue) are cytoplasmic (A, Meiosis II).
A cue (purple) from the centrosome pair (black spheres) segregates aPARs into the anterior and promotes formation of a posterior PAR domain at the opposite
pole (A, Establishment). PAR domains are then stable until cytokinesis (A,Maintenance) and drive polarization of cytoplasmic factors such asMEX-5/6 (green) and
P granules (orange), which ensure the daughter cells acquire distinct fates (A, Two-cell). (B) Symmetry breaking can occur in twoways: (i) segregation of aPARs by
cortical actomyosin flow (advection); and (ii) posterior PAR-2 loading. (C) A complex network of physical and regulatory interactions links the PAR proteins.
Membrane binding (gray lines), physical interactions (black lines), as well as positive (/) and negative (t) feedback, are shown. Where links are indirect or
unknown, dashed lines are used. Both CDC-42 and PAR-3 are required for stable membrane association of PAR-6/PKC-3. PAR-6 and PKC-3 depend on each
other for membrane association. PAR-2, LGL-1, and presumably CHIN-1, are able to load onto the membrane independently. PAR-1 also binds membrane but
requires PAR-2 to reach maximal concentrations. PKC-3 phosphorylates PAR-1, PAR-2, and LGL-1 and displaces them from the membrane. Exclusion of
CHIN-1 from the anterior is dependent on PKC-3, but whether it is a direct target of PKC-3 is unknown. Together, PAR-1, via phosphorylation of PAR-3, and
CHIN-1, by suppressing activated CDC-42, prevent invasion of the posterior domain by aPARs. PAR-3 and PAR-2 have been proposed to undergo oligomer-
ization, which is thought to enhance their membrane association (noted by circular arrows). See recent reviews (Goehring, 2014; Hoege andHyman, 2013;Motegi
and Seydoux, 2013) for more information.
(D) Midsection confocal images of fixed zygotes stained for PAR-2 at polarity maintenance and two-cell stage comparing wild-type, pkc-3(ts), and pkc-3(RNAi)
conditions.
(E) Midsection fluorescent images of mCherry:PAR-2-expressing zygotes at maintenance and two-cell stage in DMSO (control), CRT90-treated, and
pkc-3(RNAi).
(legend continued on next page)
Developmental Cell 42, 400–415, August 21, 2017 401
2001; Kay and Hunter, 2001; Schonegg and Hyman, 2006;
Tabuse et al., 1998). Consequently, loss of any of these four pro-
teins results in identical zygote polarity phenotypes: posterior
PAR proteins are found uniformly on the embryo membrane
and the first cell division is symmetric, leading to cell fate defects
and embryo lethality (Etemad-Moghadam et al., 1995; Kay and
Hunter, 2001; Tabuse et al., 1998; Watts et al., 1996).
This similarity of aPAR mutant phenotypes, their co-segrega-
tion within the anterior domain, and their ability to interact with
one another in a wide range of systems (Izumi et al., 1998; Job-
erty et al., 2000; Lin et al., 2000; Qiu et al., 2000) has led to
consideration of an effective aPAR unit comprising PAR-3,
PAR-6, PKC-3, and CDC-42. However, work across a range of
cell types suggests that such minimalism belies significant
complexity in the regulation of aPAR localization and function,
which we are only beginning to decipher.
For example, in epithelia, PAR-3 and aPKC localize to distinct
regions of the apical domain: PAR-3 is primarily junctional, while
PAR-6 and aPKCaremore apical and, together with CDC-42 and
Crumbs, exclude PAR-1 and LGL from the apical domain (Bet-
schinger et al., 2003; Harris and Peifer, 2005; Morais-De-Sa
et al., 2010; Yamanaka et al., 2006; Yamanaka et al., 2003).
In theC. elegans zygote, twomodes of aPARmembrane asso-
ciation have been proposed: one associated with PAR-3 and in-
dependent of CDC-42, and one dependent on CDC-42 but not
associated with PAR-3. Supporting this hypothesis, PAR-6 and
PKC-3 only partially co-localize with PAR-3 in wild-type em-
bryos, but co-localize strongly when CDC-42 is depleted (Beers
and Kemphues, 2006; Hung and Kemphues, 1999; Tabuse et al.,
1998). However, it remains unclear whether these observations
reflect the existence of discrete functional modules and, if so,
what their respective functions are.
A primary role of the aPAR network is to restrict PKC-3
kinase activity to the anterior domain. However, because local-
ization, function, and regulation of PKC-3 are tightly coupled,
parsing their individual contributions is difficult using traditional
RNAi and knockout studies. Consequently, despite the central
role of PKC-3 in polarity, we lack insight into how the individual
contributions by PAR-3, PAR-6, CDC-42, and PKC-3 itself
combine to ensure PKC-3 is activated only within the anterior
domain. To address these questions, we require tools to inde-
pendently modulate the localization and function of aPAR
proteins.
Here we describe methods to independently manipulate
PKC-3 activity and localization, which we use to investigate
how PKC-3 kinase activity regulates organization of the aPAR
network, and how PKC-3 activity is modulated by other network
members. We find that localized PKC-3 kinase activity is linked
to dynamic cycling of PAR-6/PKC-3 between two functionally
distinct aPAR assemblies: (1) a PAR-3-dependent assembly
that is associated with clusters and efficiently responds to polar-
izing cues, but in which PKC-3 activity is inhibited, and (2) a more
diffuse CDC-42-dependent assembly that is less able to respond
to polarizing cues but contains active PKC-3 and is responsible(F) Midsection (PAR-1, LGL-1, PIE-1, MEX-5) or cortical (CHIN-1) fluorescent imag
polarity markers in DMSO (control), CRT90-treated, and pkc-3(RNAi). Asymme
asymmetry and zero, no asymmetry (ASI, normalized to DMSO/WT controls).
*p < 0.05, **p < 0.01, ***p < 0.001, ****p < 0.0001. Scale bars, 10 mm. See also F
402 Developmental Cell 42, 400–415, August 21, 2017for posterior PAR protein exclusion. We propose that the
dynamic exchange of PAR-6/PKC-3 between these two assem-
blies allows the PAR network to efficiently translate symmetry-
breaking cues into an asymmetric homogeneous domain of
PKC-3 activity.
RESULTS
Acute Inhibition of PKC-3 Function Leads to Loss of
Asymmetric Division
We took two approaches to inhibit PKC-3 kinase activity. First,
we examined a previously identified temperature-sensitive allele
of pkc-3, ne4246 (Fievet et al., 2012), which alters a conserved
Asp residue (D386V) close to the active site. Strains carrying
pkc-3(ne4246) are subsequently referred to as pkc-3(ts).Consis-
tent with loss of PKC-3 function, in pkc-3(ts) zygotes at the
restrictive temperature (25C), PAR-2 is not restricted to the pos-
terior membrane and is partitioned symmetrically into the two
blastomeres at the first cell division (Figure 1D). Loss of asymme-
try was quantified by the asymmetry index (ASI) (see STAR
Methods), which measures the asymmetry of a feature, e.g.,
PAR-2 membrane intensity, relative to wild-type on a scale
from zero (no asymmetry) to 1 (normal asymmetry) (Figure 1D
and Movie S1). Results below and in Figure S1 indicate that
loss of asymmetry in pkc-3(ts) zygotes is due to loss of PKC-3
activity rather than degradation.
In parallel, we examined PKC-3 inhibitors in permeable,
perm-1(RNAi) embryos (Carvalho et al., 2011) to identify com-
pounds that yielded a PKC-3 deficient polarity phenotype. One
compound, CRT0103390 (CRT90), a derivative of CRT0066854
(Figures S2A–S2C) (Kjær et al., 2013; Dorsey et al., 2013) re-
sulted in embryos that progressed normally through the cell
cycle but showed loss of PAR-2 asymmetry and divided sym-
metrically (Figure 1E and Movie S1). CRT90 embryos exhibited
other common phenotypes associated with pkc-3(RNAi) and
pkc-3(ts), including simultaneous division of the two daughter
cells and ectopic spindle rotation in the anterior daughter cell,
leading to a chain-like arrangement of cells in the 4-cell embryo
(data not shown). As expected for an inhibitor of PKC-3 activity,
CRT90 treatment caused loss of asymmetry in other posterior
PAR proteins (PAR-1, LGL-1, and CHIN-1) as well as the loss
of cytoplasmic asymmetry in the cell fate determinants PIE-1
and MEX-5 (Figure 1F).
PKC-3 Inhibition Yields Distinct Phenotypes fromPKC-3
Depletion
We next investigated the distributions of the anterior PAR pro-
teins when PKC-3 activity was inhibited, and compared these
to those observed when PKC-3was depleted by RNAi. Normally,
PAR-3, PAR-6, and PKC-3 are efficiently segregated into the
anterior during the polarity establishment phase and remain
asymmetric until cytokinesis (Figures 1A and 2A–2F) (Cuenca
et al., 2003). When PKC-3 is depleted by RNAi of pkc-3, PAR-6
fails to localize to the membrane (Figure 2A) (Hung andes of maintenance-phase zygotes expressing markers to various downstream
try in (D) to (F) is quantified by the asymmetry index, with one being normal
igures S1 and S2; Movie S1.
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Figure 2. Membrane Localization of PAR-6/PKC-3 Is Decoupled from PAR-3 when PKC-3 Is Inactive
(A–F) Representative midsection confocal images of live and fixed zygotes at establishment and maintenance phase comparing control (DMSO, wild-type),
pkc-3(RNAi), and PKC-3-inhibited (CRT90, pkc-3(ts)) conditions. PAR-6 (A and B) and PKC-3 (C and D) show loss of asymmetric membrane staining in PKC-3-
inhibited zygotes at both establishment and maintenance phase (posterior localization indicated by white arrowheads). In pkc-3(RNAi), PAR-6 is absent from the
membrane at all times. PAR-3 (E and F) still polarizes in PKC-3-inhibited zygotes, but becomesweaker and less asymmetric duringmaintenance phase. Note that
(B), (D), and (F) show the same wild-type and TS zygotes with the PAR-3 boundary position in TS indicated (red arrowheads) to allow comparison: PAR-6 and
PKC-3 are clearly visible at the posterior membrane (white arrowheads), while PAR-3 is undetectable, as in wild-type. Bright foci in (D) are non-specific
centrosome staining.
(G and H) Normalized ASI measurements for late establishment phase datasets represented in (A) to (F). ASI is normalized to control (wild-type [WT] or DMSO) for
each protein.
(I and J) Anterior to posterior membrane distributions of PAR-3 (red) and PKC-3 (black) in wild-type (I) and pkc-3(ts) (J) embryos. Arrows highlight the posterior
extension of PKC-3 relative to PAR-3. Mean ± SD is shown.
(legend continued on next page)
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Kemphues, 1999). By contrast, PAR-3 remains membrane asso-
ciated and segregates into the anterior, but this population is
generally reduced compared to wild-type and is lost as the cell
proceeds through mitosis (Figure 2E) (Tabuse et al., 1998).
Unlike pkc-3(RNAi), when PKC-3 is inhibited by the D386Vmu-
tation or CRT90, PAR-6 and PKC-3 remain membrane associ-
ated, fail to segregate efficiently to the anterior, and a significant
pool of both proteins remains localized at the posterior pole re-
sulting in a loss of asymmetry relative to controls (Figures 2A–
2D, 2G, and 2H; Movie S2). In contrast to PAR-6 and PKC-3,
PAR-3 still segregates into the anterior during the establishment
phase in PKC-3-inhibited zygotes (Figures 2E and 2F, Establish-
ment). The domain is typically somewhat enlarged relative to
wild-type zygotes, but PAR-3 asymmetry remains high and
PAR-3 is absent from the posterior pole (Figures 2G and 2H).
Following the establishment phase, PAR-3 levels at the mem-
brane decline and become more symmetric (Figures 2E and
2F, Maintenance).
The distinct response of PAR-3 versus PAR-6 and PKC-3 is
particularly clear in the quantification of dual-labeled fixed zy-
gotes. In wild-type zygotes, the boundaries of the PAR-3 and
PKC-3 domains are positioned similarly at the center of the
zygote, although the PKC-3 domain extends a few microns
further into the posterior (Figures 2I and 2K, WT). By contrast,
in PKC-3-inhibited embryos, PKC-3 extends significantly further
into the posterior compared with PAR-3, a condition we refer to
as ‘‘decoupled’’ (Figures 2J–2L, TS). Consistent with this decou-
pling, upon PKC-3-inhibition we observe a decrease in co-local-
ization between PAR-3 and PAR-6 at the membrane/cortex,
even in the anterior domain where these PAR proteins overlap
(Figure S3). Thus, we conclude that PKC-3 is required for the nor-
mally tight coupling between PAR-6/PKC-3 and PAR-3 during
symmetry breaking.
These results point to an unappreciated complexity in the as-
sembly and regulation of the PAR proteins at the cell membrane:
First, the loss of membrane-associated PAR-6 in PKC-3-
depleted zygotes, but not in PKC-3-inhibited zygotes (Fig-
ure 2A), shows that disruption of PKC-3 activity or the result-
ing invasion of pPARs into the anterior (Figures 1D–1F) do not
account for loss of PAR-6 membrane association. Rather,
there appears to be a requirement for PKC-3 protein itself
to target and stabilize PAR-6 at the membrane. Consistent
with this interpretation, mutations in par-2 and par-1 fail to
rescue PAR-6 membrane localization in pkc-3(RNAi) zygotes
(Figure S4).
Second, in PKC-3-inhibited zygotes, anterior and posterior
PAR protein distributions on the membrane overlap (Figure 2M).
Posterior PAR proteins are thought to directly antagonize the
ability of anterior PAR proteins to associate with the membrane,
yet in these zygotes aPARs appear resistant to pPAR antago-
nism. PKC-3 inhibition could conceivably affect the activity of
posterior PARs. However, we found that PAR-1 kinase activity,
as measured by MEX-5 mobility (Griffin et al., 2011), appears(K) Close-up view of the boundary region showing PAR-3 (top) and PKC-3 (bottom
indicated. Dashed rectangular selection denotes regions where PKC-3 is presen
(L) PKC-3 to PAR-3 ASI ratio for wild-type (WT) and pkc-3(ts).
(M) Dual labeling of PAR-2 and PKC-3 in live, CRT90-treated zygotes (top) and fi
**p < 0.01, ***p < 0.001, ****p < 0.0001. ns, not significant. Scale bars, 10 mm. Se
404 Developmental Cell 42, 400–415, August 21, 2017normal in PKC-3-inhibited zygotes (Figures S2D–S2F). Thus,
PKC-3 activity appears necessary to render anterior PARs sen-
sitive to the antagonistic effects of posterior PARs, challenging
the simple paradigm of mutual antagonism, which would predict
pPAR dominance.
Finally, decoupling of PAR-6/PKC-3 fromPAR-3 localization in
PKC-3-inhibited zygotes during symmetry breaking suggests
that PKC-3 drives formation of distinct PAR complexes or as-
semblies during polarity establishment in the C. elegans zygote.
Contrary to what has been observed in Drosophila epithelia,
where aPKC activity promotes decoupling of PAR-3 from
PAR-6/aPKC and their targeting to distinct sites (Morais-De-Sa
et al., 2010), here we observe the opposite: PKC-3 kinase activity
is implicated in coupling the behaviors of PAR-3 and PAR-6/
PKC-3, allowing their coordinated segregation during symmetry
breaking.
PKC-3 Inhibition Promotes PAR-3-Independent
Formation of CDC-42-Dependent PAR-6/PKC-3
Assemblies
If PKC-3 inhibition favors formation or trapping of a distinct func-
tional assembly, we reasoned that it might affect the normal de-
pendencies of PAR-6 and PKC-3 on PAR-3 and CDC-42. PKC-3
and PAR-6 normally require both PAR-3 and CDC-42 to localize
stably to the membrane (Beers and Kemphues, 2006; Sailer
et al., 2015). The dependency on PAR-3 is stronger: PKC-3
and PAR-6 fail to localize to the membrane in PAR-3-depleted
zygotes (par-3(RNAi) in Figures 3A–3F) (Tabuse et al., 1998).
By contrast, in CDC-42-depleted zygotes, PKC-3 and PAR-6
initially localize to the membrane and segregate to the anterior,
but their membrane localization is gradually lost during themain-
tenance phase, becoming weaker and more uniform as zygotes
approach cytokinesis (cdc-42(RNAi) Figures 3A–3F and Movie
S4)(Beers and Kemphues, 2006; Gotta et al., 2001; Motegi and
Sugimoto, 2006; Sailer et al., 2015; Schonegg and Hyman,
2006). Importantly, depletion of PAR-1 or PAR-2, which invade
the anterior in the absence of PAR-3 or CDC-42 (Etemad-Mog-
hadam et al., 1995; Gotta et al., 2001; Kay and Hunter, 2001;
Schonegg and Hyman, 2006), fails to rescue PAR-6 membrane
localization in these conditions (Figure S4). Thus, both PAR-3
and CDC-42 are directly required to promote membrane associ-
ation of PAR-6 and PKC-3.
We find that under conditions of PKC-3 inhibition (D386V or
CRT90), PKC-3 and PAR-6 no longer depend on PAR-3 to
localize to the membrane (Figures 3A–3F and S5A; Movies S3
and S4). The degree of localization varies between the two
methods of PKC-3 inhibition, possibly reflecting differences
in the mechanism or timing/kinetics of kinase inhibition. By
contrast, CDC-42 is still required for PKC-3 and PAR-6
membrane localization in PKC-3-inhibited zygotes (Figures 3A–
3F, S5A, and S5B; Movie S4), indicating that CDC-42 is still
required for PAR-6/PKC-3 membrane targeting even when
PKC-3 is inhibited. Consistent with previous work showing that) for one representative zygote for wild-type (WT) and pkc-3(ts) backgrounds as
t in absence of PAR-3.
xed, pkc-3(ts) embryos (bottom) reveal overlap of aPAR and pPAR proteins.
e also Figures S3 and S4; Movie S2.
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Figure 3. PKC-3 Inhibition Promotes PAR-3-Independent Formation of CDC-42-Dependent PAR-6/PKC-3 Assemblies
(A–C) Representative midsection confocal images of live embryos at maintenance phase showing GFP::PKC-3 (A) or PAR-6::GFP (B and C) of DMSO, CRT90-
treated, and pkc-3(ts) zygotes subject to RNAi as indicated.
(D) Quantification of rescue for datasets represented in (A) to (C), normalized to membrane signal in control RNAi and CRT90-treated/pkc-3(ts) zygotes for each
dataset.
(E) Representativemidsection confocal images of wild-type and pkc-3(ts) zygotes during polarity establishment subject to RNAi as indicated and immunostained
for PKC-3.
(F) Quantification of rescue as measured by anterior domain cortical intensity of PKC-3 for datasets represented in (E). For each zygote, anterior PKC-3 cortical
intensity is divided by cytoplasmic intensity. Values greater than 1 indicate presence at the membrane. Mean ± 95% confidence interval (CI) (N) is shown. See
STAR Methods for further details.
(G) Representative midsection confocal images during polarity establishment of wild-type and pkc-3(ts) embryos upon cgef-1(RNAi), stained for PKC-3.
Scatterplot representing the anterior domain cortical intensity of PKC-3 as in (F) in cgef-1(RNAi) and pkc-3(ts);cgef-1(RNAi). Mean ± 95% CI (N) is shown.
**p < 0.01, ****p < 0.0001. ns, not significant. Scale bars, 10 mm. See also Figure S5; Movies S3 and S4.
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Figure 4. Segregation of Anterior PAR Proteins Involves Cortical Clusters
(A) Representative cortical images of PAR-3, PKC-3, CDC-42, and PH-PLCD1 in late-establishment and maintenance-phase zygotes along with zoom of inset
region (yellow box).
(B) Time-averaged cortical images spanning 180 s reveal anterior-directed tracks of cortical clusters of PAR-3, PAR-6, and PKC-3. Insets highlight the motion
(arrows) of a representative single cluster in the image above.
(C) Cluster index for the full dataset in (A) and PAR-6::GFP (images not shown). Significance between establishment andmaintenance: p < 0.01 for PAR-3, PAR-6,
and PKC-3.
(D) Representative midsection or cortical images of PAR-3::GFP (WT) or PAR-3DCR1::GFP (DCR1) with and without co-expression of the membrane tether
PH::GBP (±GBP) shown at symmetry-breaking, establishment, or maintenance phase. Note enhancement ofmembrane signal visible in GBP-expressing zygotes
viewed in midsection and lack of bright clusters of PAR-3DCR1::GFP viewed at the cortex.
(E) Cluster index for WT andDCR1 in the presence of the PH-GBPmembrane tether (+GBP) alongwith magnification of insets (yellow dashed-line rectangles in D)
indicated to highlight the difference in clustering.
(F) Representative midplane images of WT and DCR1 subject to GBP-membrane targeting showing defective segregation of DCR1. Images shown are from late-
establishment phase.
(legend continued on next page)
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PAR-6/aPKC are typically associated with an active, guanosine
triphosphate (GTP)-bound form of CDC-42 (Atwood et al.,
2007; Gotta et al., 2001; Joberty et al., 2000; Lin et al., 2000;
Qiu et al., 2000), we found that decreasing CDC-42/GTP by
depletion of the CDC-42 GEF, CGEF-1, reduces membrane as-
sociation of PAR-6/PKC-3 in pkc-3(ts) embryos compared with
wild-type, while leaving PAR-3 levels unchanged (Figures 3G
and S5A–S5E). Finally, PKC-3 remains dependent on PAR-6 in
PKC-3-inhibited embryos, consistent with PAR-6 being required
to mediate the interactions of the PAR-6/PKC-3 heterodimer
with PAR-3 and/or CDC-42 (Figures 3A and 3D–3F; Movie S4)
(Joberty et al., 2000; Qiu et al., 2000), as well as our general
findings that PKC-3 and PAR-6 respond similarly in all assays
described.
Thus, inhibition of PKC-3 activity allows PKC-3 to bypass
its normal requirement on PAR-3 to load onto the membrane
and form stable membrane-associated CDC-42/GTP-depen-
dent complexes. We postulate that it is this dependency on
PAR-3, enforced by PKC-3 kinase activity, that ensures the
coupled distributions of PKC-3 and PAR-3 in the embryo.
Segregation of Anterior PAR Proteins Is Associated with
PAR-3-Dependent Clustering at the Membrane
So far, we have shown that inhibition of PKC-3 kinase activity
promotes CDC-42-dependent assemblies, and in so doing pre-
vents PKC-3 and PAR-6 from segregating efficiently with PAR-3
into the anterior during symmetry breaking. Previous work has
shown that the efficient segregation of anterior PAR proteins is
due to advective transport by anteriorly-directed actomyosin
cortical flow (Cheeks et al., 2004; Goehring et al., 2011b; Munro
et al., 2004). Because PAR-3 continues to be segregated effi-
ciently in PKC-3-inhibited zygotes, we reasoned that PKC-3 inhi-
bition may selectively alter the molecular organization of PAR-6
and PKC-3 at the membrane relative to PAR-3, which would
be consistent with the observed shift toward CDC-42-depen-
dent PKC-3 assemblies.
To investigate these possibilities, we imaged PAR-3, PAR-6,
and PKC-3 at the membrane using variable-angle epifluores-
cence microscopy (VAEM or pseudo-TIRF) (Konopka and
Bednarek, 2008). All three proteins exhibit a distinct clustered
appearance during the polarity establishment phase, consistent
with reports of non-homogenous distributions of PAR proteins at
the membrane (Figures 4A and 5A, Establishment) (Munro et al.,
2004; Robin et al., 2014; Sailer et al., 2015). Similar to previous
analysis of PAR-6 (Munro et al., 2004), we find that clusters of
PAR-6, PAR-3, and PKC-3 move in a highly directional manner
in the direction of cortical flow, coinciding with increasing overall
asymmetry (Figure 4B and Movie S5). While aPAR clusters have
been noted (Hung and Kemphues, 1999; Munro et al., 2004;
Sailer et al., 2015), the relationship between clustered and
non-clustered PAR proteins and their ability to segregate in
response to flow has not been explored.
To test whether clustering is a key driver of aPAR segregation,
we examined whether PAR-3 transport depends on its ability(G) Membrane intensity profiles for the full dataset represented in (F), showing a
expansion of the PAR-3 domain boundary.
(H) ASI quantification of membrane intensity profiles in (G) showing significant re
**p < 0.01, ***p < 0.001. ns, not significant. Scale bars, 10 mm. See also Movie Sto cluster. PAR-3 contains a conserved CR1 oligomerization
domain, which is required for membrane binding and is targeted
by PAR-1 kinase to induce displacement form the membrane
(Benton and St Johnston, 2003; Feng et al., 2007; Li et al.,
2010; Mizuno et al., 2003). We reasoned that this domain would
be required for clustering; however, because mutations in the
CR1 domain disrupt membrane binding (Figure 4D, WT versus
DCR1), assessing clustering and segregation of a PAR-3DCR1
mutant requires an alternative mode of membrane targeting.
We restored membrane localization of GFP:PAR-3DCR1 using
a membrane-tethered anti-GFP nanobody (PH-GBP) and
compared this with the behavior of GFP:PAR-3 (wild-type) that
was also tethered to the membrane via PH-GBP. Targeting
both wild-type and DCR1 to the membrane with PH-GBP re-
duces potential confounding effects of PAR-1-induced mem-
brane displacement in the posterior. Thus, differences in segre-
gation in PAR-3DCR1 relative to wild-type should be due to
changes in clustering rather than differential sensitivity to PAR-1.
Consistent with oligomerization being required for clustering,
membrane-tethered PAR-3DCR1 exhibited more diffuse mem-
brane localization compared with wild-type controls (Figures
4D and 4E, WT + GBP versus DCR1 + GBP). PAR-3DCR1 also
showed reductions in both segregation into the anterior and
overall asymmetry (Figures 4F–4H and Movie S5). Thus, the abil-
ity of the CR1 domain to drive formation of membrane-associ-
ated PAR-3 clusters ensures that PAR-3 is efficiently transported
by cortical flows in addition to its known role in promoting mem-
brane association.
Balance between PAR-3 and CDC-42 Assemblies Tunes
Cortical Organization and Sensitivity to Cortical Flow
The correlation between lack of PAR-3 clustering and defects
in advective transport prompted us to examine the organization
of anterior PAR proteins at the membrane in more detail.
Although PAR-6 and PKC-3 exhibit a distinct clustered appear-
ance similar to PAR-3 during polarity establishment, clusters
are less pronounced and accompanied by a background of a
more diffuse population (Figures 4A, 4C, and 5A). By contrast,
CDC-42 exhibits a more uniform signal overall that resembles
typical membrane markers, such as the PIP2 (phosphatidylinosi-
tol-4,5-bisphosphate) probe PH-PLCD1 (Figures 4A and 4C).
Membrane markers do exhibit enriched signals in membrane
folds and protrusions, which are also enriched in the anterior,
but these signals are clearly distinguishable from clusters.
With the transition into maintenance phase, clusters of PAR-6
and PKC-3 become less prominent and a diffuse population
dominates. This change coincides temporally with a decrease
in the prominence of PAR-3 clusters and an overall reduction
in PAR-3 membrane localization (Figures 4A and 4C) as well as
an increase in anterior CDC-42 activity (Figures S5C–S5E)
(Kumfer et al., 2010). We therefore speculated that the mix
of diffuse and clustered PAR-6/PKC-3 observed during estab-
lishment phase may reflect the distinct CDC-42- and PAR-3-
dependent assemblies that we describe above. Consequently,verage (solid line) and full range of data (shaded). Arrow highlights posterior
duction in asymmetry in the DCR1 mutant.
5.
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Figure 5. Regulation of PKC-3/PAR-6 Cluster Association by PAR-3/CDC-42 Balance Tunes Responsiveness to Cortical Flows
(A) Representative cortical images of PAR-6::GFP at late-establishment and maintenance-phase embryos for indicated conditions, shown along with a zoom of
inset region (white boxes).
(B) Cluster index measurements of full dataset reveal a gradient of cluster association across conditions. Note that clustering decreases when embryos enter
maintenance phase, except for CRT90/par-3(RNAi) embryos, which show minimal clustering even in establishment phase.
(C) ASI measurements of midsection images taken at late-establishment phase for a similar set of embryos as in (A) and (B), but expressing GFP::PKC-3, show a
similar trend.
(D) Profiles of membrane signal for zygotes in (C) showing average (solid line) and full range of data (shaded) reveal shift of the PKC-3 domain boundary (arrows)
toward the anterior in cdc-42(RNAi) embryos and toward the posterior in CRT90-treated zygotes, resulting in significantly (p < 0.01) smaller and larger domain
sizes, respectively.
(legend continued on next page)
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cell-cycle-dependent changes in the balance between assembly
types could effectively tune the system to promote efficient
transport of aPAR species during the polarity establish-
ment phase.
To test this hypothesis, we altered the balance between
CDC-42- and PAR-3-dependent assemblies and monitored the
corresponding changes in (1) organization at the membrane,
and (2) segregation efficiency. In general, we find a striking cor-
relation between quantitative measures of cortical clustering and
overall asymmetry.
Depletion of CDC-42 is known to increase co-localization of
PAR-6 with PAR-3 during polarity establishment (Beers and
Kemphues, 2006). We find that this also increases overall clus-
tering of PAR-6 (Figures 5A and 5B). Examination of PKC-3 dis-
tributions clearly reveals enhanced segregation, with increased
ASI (Figure 5C) and a visibly steeper domain boundary that is
shifted toward the anterior (Figure 5D), resulting in a smaller
anterior domain (*p < 0.01). Consistent with these data, we
also observe a tighter coupling between the PAR-3 and PKC-3
domain boundaries in dual-labeled fixed zygotes (Figure 5K).
In contrast to CDC-42 depletion, inhibition of PKC-3 using
CRT90, which favors CDC-42-dependent assemblies, shows
reduced clustering of PAR-6, which could be reduced further
by also depleting PAR-3 (Figures 5A and 5B). Under these con-
ditions that favor CDC-42-dependent assemblies and reduced
clustering, PKC-3 segregated less efficiently than DMSO con-
trols, exhibited a reduced ASI, and failed to be fully excluded
from the posterior (Figures 5C and 5D). To confirm that this
reduction in clustering and segregation is due to favoring CDC-
42-dependent assemblies, we examined the effect of expressing
CDC-42 (Q61L), which stabilizes the active GTP-bound form of
CDC-42 (Aceto et al., 2006; Ziman et al., 1991). Unlike PKC-3 in-
hibition, CDC-42 (Q61L) does not efficiently bypass the normal
dependence of PKC-3 on PAR-3 (Figures S5F–S5J). This sug-
gests that inhibition of PKC-3 favors CDC-42-associated assem-
blies via a mechanism distinct from stabilizing the GTP-bound
form of CDC-42. However, similar to what we see when PKC-3
is inhibited, expression of CDC-42 (Q61L) reduced clustering
and resulted in less efficient segregation of PKC-3 (Figures 5F–
5K). Thus, regardless of the mechanism by which we alter the
balance between PAR-3- and CDC-42-dependent assem-
blies, we achieve similar effects on clustering and segregation.
This is particularly striking when we plot mean cluster index
versus asymmetry across all conditions at establishment phase
(Figure 5E).(E) Combining clustering data from pseudo-TIRF imaging in (A) and (B) and (F)
establishment phase across all conditions allows us to plot cluster index vers
regression: R2 = 0.85, p < 0.01).
(F–I) Representative cortical images (F, full zygote and inset zoom), cluster inde
phase zygotes expressing GFP::PKC-3 in combination with either CDC-42(WT) or
(J) Profiles of membrane signal for zygotes in (I) showing average (solid line) and fu
boundary in Q61L-expressing zygotes (p < 0.05). Profiles for wild-type (solid bla
(K) Quantification of the difference in boundary position between PAR-3 and PKC
shown. Positive values indicate reduced PKC-3 segregation relative to PAR-3. R
42(WT) of CDC-42 (Q61L). Yellow arrowheads indicate the posterior boundary o
(L andM) Comparison of cortical flow velocities (L) and PKC-3 asymmetry (M, ASI)
(N) A plot of PKC-3 ASI versus cortical flow rates for individual zygotes treated wit
with a 90% confidence boundary (shaded region).
*p < 0.05, **p < 0.01, ***p < 0.001, ****p < 0.0001. ns, not significant. Scale bars,Because PAR proteins are known to regulate actomyosin
dynamics (Cheeks et al., 2004; Munro et al., 2004), and changes
in flow velocities could, in principle, affect advective transport
(Goehring et al., 2011b), we wanted to confirm that clustering
rather than potential changes in flow velocity were the cause of
reduced segregation efficiency. Measurements of flow rates
from yolk granule motion in differential interference contrast
(DIC) images allowed us to test the relationship between cortical
flow rates and asymmetry in individual zygotes. Consistent with
anterior PARs promoting their own segregation via stimulation of
cortical flows, we find that PKC-3 inhibition results in a reduction
of flow rates from approximately 6–10 mm/min in controls to
approximately 2–5 mm/min in CRT90-treated embryos (Fig-
ure 5L). To test whether alterations in flow velocities could ac-
count for the observed segregation defects, we performed a par-
tial depletion of MLC-4 to generate embryos with flow velocities
of a similar range as observed in PKC-3-inhibited embryos
(Figure 5L). Despite a similar range of flow velocities, MLC-4-
depleted zygotes show aminimal reduction in asymmetry versus
controls (Figures 5M and S6A). Plotting flow velocity versus ASI
reveals a weak decline in ASI as flow rates are reduced (Fig-
ure 5N). By contrast, CRT90-treated embryos show a lower
ASI across the full range of observed flow rates (2–5 mm/min,
Figures 5N and S6A). Finally, to test whether restoring flows
could rescue efficient segregation of PKC-3, we used RNAi to
target the RhoGAPs, RGA-3/4, which results in excess actomy-
osin contractility and increased cortical flow rates (Fievet et al.,
2012; Schonegg et al., 2007). Despite fully rescuing the moder-
ate reduction in asymmetry of PAR-3 observed in pkc-3(ts) em-
bryos to levels indistinguishable from wild-type, RGA-3/4 deple-
tion failed to restore asymmetry of PKC-3 (Figures S6B
and S6C).
Together these data suggest that it is the failure of PKC-3 to
associate with clusters rather than changes in flow rates that
are the dominant factor in the decoupling between the localiza-
tion of PAR-3 and PAR-6/PKC-3 observed in PKC-3-inhibited
embryos. In fact, the resilience of PKC-3 asymmetry in embryos
partially depleted of MLC-4 suggests that there is a relatively low
threshold velocity required for efficient segregation of aPAR
proteins by cortical flow, provided aPARs are able to associate
normally into clusters.
We therefore conclude that although both PAR-3 and CDC-
42 are critical for normal PAR-6/PKC-3 localization at the
membrane in wild-type embryos, they drive formation of
distinct aPAR assemblies, with distinct physical properties andand (G) with ASI measurements of a complete GFP::PKC-3 dataset for late-
us ASI for the mean of each condition, revealing a strong correlation (linear
x (G), representative midsection images (H), and ASI (I) for late-establishment
CDC-42 (Q61L). Yellow arrowheads in (H) highlight PKC-3 domain boundaries.
ll range of data (shaded) highlight the posterior shift (black arrow) of the PKC-3
ck line) and CRT90-treated (dashed line) from (D) shown for comparison.
-3 in dual-labeled fixed zygotes for indicated conditions. Mean ± 95% CI (N) is
epresentative images of PAR-3 and PKC-3 in zygotes overexpressing CDC-
f the PAR-3 or PKC-3 domains.
for DMSO, CRT90, ormlc-4(RNAi) embryos taken at late-establishment phase.
h DMSO, CRT90, ormlc-4(RNAi). Data points for individual embryos are shown
10 mm. See also Figure S6.
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responsiveness to cortical flow: PAR-3-dependent assemblies
exhibit pronounced clustering, at least during the establishment
phase, and are efficiently segregated by cortical flow. By
contrast, CDC-42-dependent assemblies are more diffuse, likely
reflecting enhanced diffusional mobility, and are inefficiently
segregated by flow. Importantly, the balance between these
two species appears to be subject to cell-cycle-dependent regu-
lation to ensure maximal clustering and transport during the
period of peak actomyosin cortical flows.
A PKC-3 Membrane-Targeting Assay Reveals Opposing
Roles for PAR-3 and CDC-42 in Regulating PKC-3
Activity
We next sought to explore whether there were other functional
differences in these two types of assemblies. Specifically, we
wondered whether PAR-3 and CDC-42 may have distinct regu-
latory effects on PKC-3 activity in vivo, which is difficult to
analyze given their roles in PKC-3 membrane loading. While
CDC-42 is generally thought to play an activating role (Atwood
et al., 2007; Gotta et al., 2001; Joberty et al., 2000; Lin et al.,
2000; Qiu et al., 2000), the roles for PAR-3 and PAR-6 are less
clear and may vary in different contexts (Achilleos et al., 2010;
Atwood et al., 2007; David et al., 2013; Graybill et al., 2012;
Lin et al., 2000; McCaffrey and Macara, 2009; Wirtz-Peitz
et al., 2008).
To directly assess whether PKC-3 activity differs in PAR-3-
associated and CDC-42-associated assemblies in vivo, we tar-
geted PKC-3 to the membrane by fusing it to the C1B domain
of human PKCa, which can be induced to bind the membrane
by the addition of phorbol ester (Figure 6A) (Lekomtsev et al.,
2012). This bypasses the membrane-binding requirement of
PKC-3 on PAR-3, PAR-6, and CDC-42, allowing us to test their
contribution to PKC-3 activity by monitoring membrane removal
of the PKC-3 target, PAR-2.
In the absence of phorbol ester, C1B-PKC-3 mirrors endoge-
nous PKC-3 localization and is anteriorly enriched, with PAR-2
restricted to the posterior as in wild-type (Figure 6B, No PMA).
Upon addition of 100 mM phorbol 12-myristate 13-acetate
(PMA), C1B-PKC-3 is recruited uniformly to the membrane and
the PAR-2 domain shrinks, consistent with an increase in poste-
rior PKC-3 activity (Figure 6B, +PMA; Figure 6C; Movie S6). The
reduction in PAR-2 domain size is not seen in the absence of
PMA, when targeting the C1B domain alone to the membrane,
or if we inhibit PKC-3with CRT90 (Figures 6B and 6D). The failure
to completely remove PAR-2 in polarized zygotes is not simply
due to PAR-2 being concentrated in a domain, because ectopic
PAR-2 domains that form in meiotic arrest mutants, e.g., mei-1
and emb-27 (Wallenfang and Seydoux, 2000), are rapidly cleared
(Figure S7).
In par-3, par-6, or cdc-42(RNAi) zygotes, both endogenous
PKC-3 and the C1B-PKC-3 fusion are cytoplasmic in the
absence of PMA, allowing PAR-2 to localize uniformly to the
membrane (Figures 6E and 6F). In par-6 and cdc-42(RNAi) zy-
gotes, membrane targeting of C1B-PKC-3 (+PMA) has no effect
on PAR-2 distribution: it remains uniformly enriched at the mem-
brane with no difference compared with controls in which C1B
alone is targeted to the membrane (Figures 6E and 6F; Movie
S7). Thus, both PAR-6 and CDC-42 are required for PKC-3 activ-
ity in vivo.410 Developmental Cell 42, 400–415, August 21, 2017By contrast, membrane targeting of C1B-PKC-3 in par-
3(RNAi) zygotes induces rapid loss of PAR-2 from the mem-
brane, with near complete removal within minutes (Figures 6E
and 6F; Movie S7). The displacement of PAR-2 is stronger than
in wild-type zygotes, suggesting that PAR-3 normally acts to
inhibit or suppress PKC-3 activity (Figure 6B, +PMA). Thus
PAR-3 has two roles in vivo: it promotes PKC-3 membrane tar-
geting while at the same time limiting its activation, reconciling
in vivo reports whereby PAR-3 positively regulates PAR polarity
(Achilleos et al., 2010; McCaffrey and Macara, 2009) with data
indicating that PAR-3 can inhibit PKC-3 activity in vitro (Graybill
et al., 2012; Lin et al., 2000; Soriano et al., 2016).
DISCUSSION
Taken together, our data suggest that efficient polarization re-
quires PKC-3 to cycle between functionally specialized modules
of the anterior PAR network: a PAR-3-dependent module that
segregates in response to symmetry-breaking signals, but which
is inactive, and a CDC-42-dependent module that uses spatial
information provided by PAR-3 to create an anterior domain of
PKC-3 activity on the membrane (Figure 7).
In previous work, we showed that the diffusion andmembrane
dissociation rates of aPARs were in principle sufficient to explain
segregation in response to flows (Goehring et al., 2011b). Here
we show that segregation of aPARs is directly linked to PAR-3-
dependent clustering. Clustering reduces the effective diffusion
of membrane-associated aPARs, which should favor advective
transport. Alternatively, the sheer size of clusters may allow
them to sense flow that would not affect individual proteins,
possibly by allowing them to extend into the cortical actomyosin
layer. Regardless of the physical mechanism, as we show here,
clustering drives robust segregation of PAR-3 by cortical flow.
This fact, coupled with PAR-3 exclusion from the posterior
by PAR-1-dependent phosphorylation (Motegi et al., 2011),
supports a model in which PAR-3 is responsible for sensing
asymmetry-generating cues. Importantly, once it is asymmetric,
PAR-3 provides a landmark for polarized loading of PAR-6/PKC-
3, explaining recent observations that PAR-6 loads preferentially
in the anterior of polarized embryos (Sailer et al., 2015).
Because our in vivo PKC-3 activity assay indicates that PKC-3
activity is suppressed within PAR-3-dependent assemblies,
PAR-6/PKC-3 molecules must be converted into an activated
CDC-42-dependent species, a state that we show is non-clus-
tered and diffusive. Whereas this diffusive behavior of CDC-42-
assemblies is a disadvantage for transport by cortical flow, it is
an advantage for creating a uniform, wider-range field of
PKC-3 activity that can efficiently exclude pPARs. If the same
complexes had to respond to flow and exclude pPARs, there
would be a trade-off between efficiency of transport by flow
and uniformity of pPAR inhibition at the anterior.
For this field of activated CDC-42-dependent PKC-3 assem-
blies to remain coupled to the spatial information provided by
PAR-3, two conditions must be satisfied. First, PKC-3 mem-
brane localization must be dependent on PAR-3, and second,
diffusion of CDC-42-associated PKC-3 away from loading sites
must be limited, with PKC-3 ultimately being released back
into the cytoplasm, where it again becomes dependent on
PAR-3. This turnover restricts the effective distance these
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Figure 6. PAR-3 and CDC-42 Have Opposing Regulatory Roles in an In Vivo PKC-3 Activity Assay
(A) C1B targeting strategy for inducing PKC-3 membrane loading by PMA. PKC-3 kinase activity is monitored by following loss of PAR-2 from the
membrane.
(B) Zygotes expressing GFP::C1B alone (GFP::C1B-Ø) or GFP::C1B-PKC-3 along with mCherry::PAR-2 were subject to the indicated treatment. Note that
uniform membrane targeting of C1B-PKC-3 leads to reduction of PAR-2 domain size, whereas omitting PMA or expressing C1B alone has no effect. Right:
cartoon representation of results.
(C) Quantification of PAR-2 domain size ratio for embryos shown in (B).
(D) PAR-2 retention in GFP::C1B-PKC-3 expressing zygotes treated with PMA and CRT90 confirms that induced PAR-2 loss is dependent on PKC-3 kinase
activity.
(E) Zygotes expressing mCherry::PAR-2 with GFP::C1B-Ø or GFP::C1B-PKC-3 subject to par-6, cdc-42, or par-3(RNAi) before and 5 min after PMA addition.
(F) Quantification of PAR-2 cortex retention comparing GFP::C1B-PKC-3 and GFP::C1B-Ø zygotes after treatment with PMA as in (E).
Representative midsection confocal images are shown in (B), (D), and (E) before and 5min after PMA/DMSO addition. ***p < 0.001. ns, not significant. Scale bars,
10 mm. See also Figure S7; Movies S6 and S7.
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Figure 7. Polarization through Coupling
of PAR-3- and CDC-42-Dependent aPAR
Assemblies
(i) PKC-3 kinase activity ensures that PKC-3 loads
via a PAR-3 intermediate, in which PKC-3 activity is
suppressed. This dependence on PAR-3 can be
bypassed upon inhibition of PKC-3 (dashed arrow).
(ii) Clustering of membrane-associated PAR-3
allows it to be segregated by cortical flow into
the anterior, carrying along associated PKC-3
molecules and generating asymmetric sites for
further PKC-3 loading. (iii) PKC-3 activation re-
quires conversion into a CDC-42-associated
assembly, which relieves inhibition of PKC-3 by
PAR-3. (iv) The CDC-42-dependent module is
freely diffusible on the membrane and locally ex-
cludes pPARs. (v) Dissociation of CDC-42-depen-
dent assemblies limits the spread of active PKC-3
at themembrane from the PAR-3 recruiting site. (vi)
PKC-3 returns to the cytoplasm where it must load
again via PAR-3.complexes can diffuse from their initial sites of formation,
defining an effective ‘‘sphere of influence’’ around PAR-3 loading
sites. Together, these requirements result in a cycle of localized
membrane loading, activation, and release (Figure 7).
Our data suggest that the first of these requirements, PAR-3-
dependent loading, is dependent on the kinase activity of
PKC-3 itself, although the precise mechanism is unclear. Given
the limited ability of CDC-42 (Q61L) to rescue PKC-3 membrane
localization in PAR-3-depleted embryos, PKC-3 is likely to act at
the step of CDC-42 complex generation, either inhibiting its
own association with CDC-42, and/or destabilizing nascent
CDC-42/PAR-6/PKC-3 assemblies. We speculate that it could
be the very act of inhibiting PKC-3 through which PAR-3 pro-
motes generation of stable CDC-42-dependent assemblies, but
further work will be required to reveal the details of this molecular
handover. Because the inhibitory role of PAR-3 appears to be
broadly conserved (David et al., 2013; Graybill et al., 2012; Lin
et al., 2000; McCaffrey et al., 2012; Soriano et al., 2016), this
apparent paradoxical role of PAR-3 in promoting formation of
membrane-associated aPKC complexes, yet also suppressing
PKC-3 activity, may be a general feature of aPKC regulation.
How diffusion of CDC-42-associated PKC-3 is limited also
remains unclear. Measurements elsewhere suggest that the
distance these activated assemblies travel is on the order of
5–10 mm (Goehring et al., 2011a; Robin et al., 2014), consistent
with the PKC-3 gradient extending further into the posterior
than PAR-3 during the establishment phase even in wild-type412 Developmental Cell 42, 400–415, August 21, 2017le
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utembryos (see Figure 2I). Because CDC-42
assemblies appear to be resistant
to removal by posterior PAR proteins
(Figure 2M), including the CDC-42 GAP
CHIN-1, it seems likely that it is not prefer-
ential removal of these complexes in
the posterior by pPARs, but rather the
intrinsic lifetime of CDC-42-dependent
PKC-3 assemblies that limits their diffu-
sion into the posterior. This is compatibwith a model in which aPKC undergoes asymmetric membra
loading but symmetric dissociation (Robin et al., 2014).
By loading PKC-3 via what we presume is an inhibited PAR-
associated state, which must then be activated, PKC-3 localiz
tion and activation are segregated into distinct modules of t
PARnetwork,whichcanbe regulated independently. This divisi
of labor may be critical for PAR proteins, which operate acro
diverse contexts, where the polarity cues, substrates, scale
and even the concentrations of PAR molecules themselves m
vary substantially. Even within the C. elegans zygote, the mech
nisms of PAR segregation vary. During polarity establishme
when cortical flow is the major cue for anterior PAR segregatio
PAR-3 clustering is prominent (Cheeks et al., 2004; Goehri
et al., 2011b; Munro et al., 2004). As the system enters the ma
tenance phase, flowceases and continued aPAR segregation b
comes dependent on the activity of PAR-1 and CHIN-1 (Bea
et al., 2013; Guo and Kemphues, 1995; Kumfer et al., 2010; Sai
et al., 2015). Notably, clustering appears to be reducedduring th
phase,whichDickinson et al. (2017) show is dependent onPLK-
This change in PARmolecular organization potentially reflects t
shift in the spatial signals towhich thePARnetworkmust respon
At the same time, despite these changes, PKC-3 activity mu
remain efficient at displacing pPARs from the anterior doma
highlighting the adaptability of the PAR network.
In summary, here we have identified a critical role for t
separation of signal-receiving and signal-transducing functio
between modules of the aPAR network that are distinct, b
coupledviadynamicexchangeof thesharedsignalingcomponent,
PKC-3. We suggest that functional specialization of coupledmod-
ules resolves potential molecular constraints between compo-
nents that must be sensitive to polarity cues and those that must
propagate thesignals. It further allows thesystemto independently
modulate responsiveness to cues as well as the extent and
strength of the output signal. The adaptability of such a paradigm
suggests it is likely to bea commonstrategy in patterning systems.
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STAR+METHODSKEY RESOURCES TABLEREAGENT or RESOURCE SOURCE IDENTIFIER
Antibodies
Rabbit Anti-PAR-2 (Dong et al., 2007) N/A
Rabbit Anti-PAR-6 (Gotta et al., 2001) N/A
Rat Anti-PKC-3 (Tabuse et al., 1998) N/A
Mouse Anti-PAR-3 Developmental Studies Hybridoma Bank P4A1; RRID: AB_528424
Mouse Anti-aTubulin Sigma DM1A (T9026); RRID: AB_477593
Rabbit Anti-pLLGL1/2(S650/S654) Abnova PAB4657; RRID: AB_1577970
a-rabbit-Alexa488/594/647 Molecular Probes RRID: AB_2576217 / RRID: AB_2534095 /
RRID: AB_2535813
a-mouse-Alexa488/594/647 Molecular Probes RRID: AB_138404 / RRID: AB_141672 /
RRID: AB_141725
a-rat-Alexa488/594/647 Molecular Probes RRID: AB_141373 / RRID: AB_141374 /
RRID: AB_141778
a-mouse-HRP DAKO P0447; RRID: AB_2617137
a-rat-HRP DAKO P0450; RRID: AB_2630354
Bacterial and Virus Strains
E. coli: OP50: E. coli B, uracil auxotroph CGC WB Strain: OP50
E. coli: HT115(DE3): F-, mcrA, mcrB,
IN(rrnD-rrnE)1, rnc14::Tn10(DE3 lysogen:
lavUV5 promoter-T7 polymerase).
CGC WB Strain: HT115(DE3)
E. coli : DH5a Electrocompetent cells Gift from Colin Dolphin N/A
Chemicals, Peptides, and Recombinant Proteins
aPKC inhibitor: CRT0103390 Cancer Research Technology LTD CRT0103390
phorbol 12-myristate 13-acetate (PMA) Sigma-Aldrich Cat#P1585-1MG
PKCi-(recombinant human baculovirus-
expressed)
EMD Millipore Cat#14-505
PKCz-(recombinant active protein,
His tagged, Sf21 cells-expressed)
EMD Millipore Cat#14-525
FAM-PKC 3-pseudosubstrate Molecular Devices Cat#RP7548
ATP Sigma-Aldrich Cat#A7699
Critical Commercial Assays
IMAP fluorescence polarization
progressive binding system
Molecular Devices #R8127
KINOMEscan DiscoveRx N/A
Deposited Data
CRT0103390 synthesis Patent WO/2013/078126
pkc-3(ne4246) Allele Sequence ne4246
Experimental Models: Cell Lines
HEK-293 Cell Production, Cancer
Research UK (CRUK)
HEK-293
Experimental Models: Organisms/Strains
C. elegans: N2 (Bristol) CGC WB Strain: N2
C. elegans: HT1593: unc-119(ed3) III. CGC WB Strain: HT1593
C. elegans: DR466: him-5(e1490) V. CGC WB Strain: DR466
C. elegans: DP38: unc-119(ed3) III; daf-?. CGC WB Strain: DP38
C. elegans: JA1643[gfp::wsp-1; pkc-3
(ts)]: ojIs40 [Ppie-1::gfp::GBDwsp-1 +
unc-119(+)];pkc-3(ne4246)II
this paper JA1643
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C. elegans: JA1644[gfp::cdc-42;
pkc-3(ts)]: unc-119(ed3) III; tjIs6
[Ppie-1::gfp::cdc-42 + unc-119(+)];
pkc-3(ne4246)II.
this paper JA1644
C. elegans: JH2802[Dendra2::MEX-5]:
unc-119(ed3) III; axIs1950[mex-5p::
Dendra2::TEV::S-peptide::mex-5RR::
mex-5 3’UTR + unc-119(+)]
CGC WB Strain: JH2802
C. elegans: JH2840[mCherry::mex-5]:
axIs??? [nmy-2p::pgl-1::GFP::patr-1::
nmy-2 3’UTR]. axIs1731 [pie-1p::
mCherry::mex-5::pie-1 3’UTR + unc-119(+)]
CGC WB Strain: JH2840
C. elegans: KK1063[lgl-1::gfp]: it256
[lgl-1::gfp + unc-119(+)]; unc-119(ed4) III;
lgl-1(tm2616) X
(Beatty et al., 2010) WB Strain: KK1063
C. elegans: KK114[par-2(ts)]:
daf-7(e1372) par-2(it5) III
CGC WB Strain: KK114
C. elegans: KK1216[par-3::gfp]:
par-3(it298 [par-3::gfp]) III
Ken Kemphues / CGC WB Strain: KK1216
C. elegans: KK1228[gfp::pkc-3]:
pkc-3(it309 [gfp::pkc-3]) II
Liam Coyne
Ken Kemphues / CGC
WB Strain: KK1228
C. elegans: KK1248[par-6::gfp]:
par-6(it310[par-6::gfp]) I
Anushae Syed
Ken Kemphues / CGC
WB Strain: KK1248
C. elegans: KK1262[par-1::gfp]:
par-1 (it324[par-1::gfp::par-1 exon 11a])
Diane Morton / CGC WB Strain: KK1262
C. elegans: KK822[par-1(ts)]:
par-1(zu310) V
CGC WB Strain: KK822
C. elegans: KK973[par-3:Dcr1:gfp]:
itIs169 [Ppar-3::par-3 CR1 D(69-82):::gfp,
unc-119(+)]; unc-119(ed4) III
Ken Kemphues KK973
C. elegans: NWG0003[par-2(ts); gfp::
par-6]: daf-7(e1372) par-2(it5) III; unc-119
(ed3) III; ddIs8 [gfp::par-6(cDNA); unc-119(+)]
this paper NWG0003
C. elegans: NWG0012[gfp::c1b]:
unc-119(ed3)III; crkIs4[Ppie-1::sfgfp::
c1b::pie-1utr; unc-119(+)]
this paper NWG0012
C. elegans: NWG0016[gfp::c1b::pkc-3]:
unc-119(ed3)III; crkIs10[Ppie-1::sfgfp::
c1b::pkc-3::pie-1utr; unc-119(+)]
this paper NWG0016
C. elegans: NWG0021[gfp::c1b::pkc-3;
mCherry::par-2]:unc-119(ed3)III;
ddIs31[pie-1p::mCherry::par-2::pie-1utr;
unc-119(+)]; crkIs10[Ppie-1::sfgfp::c1b::
pkc-3::pie-1utr; unc-119(+)]
this paper NWG0021
C. elegans: NWG0022[gfp::c1b;mCherry::
par-2]: unc-119(ed3)III; ddIs31[pie-1p::
mCherry::par-2::pie-1utr; unc-119(+)];
crkIs4[Ppie-1::sfgfp::c1b::pie-1utr; unc-119(+)]
this paper NWG0022
C. elegans: NWG0026[par-6::gfp; mCherry::
par-2]: par-6(it310[par-6::gfp]) I;unc-119
(ed3)III; ddIs31[pie-1p::mCherry::par-2; unc-119(+)]
this paper NWG0026
C. elegans: NWG0027[gfp::pkc-3; mCherry::
par-2]: pkc-3(it309 [gfp::pkc-3]) II;unc-119(ed3)III;
ddIs31[pie-1p::mCherry::par-2; unc-119(+)]
this paper NWG0027
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C. elegans: NWG0028[par-3::gfp; mCherry::par-6]:
par-3(it298 [par-3::gfp]) III;unc-119(ed3)III;ddIs26
[mCherry::T26E3.3;unc-199(+)]
this paper NWG0028
C. elegans: NWG0039[par-1(ts); par-6::gfp]:
par-1(zu310) V; par-6(it310[par-6::gfp]) I.
this paper NWG0039
C. elegans: NWG0047[PH-GBP]:
unc-119(ed3) III; crkEx1[pNG19:
mex-5p::PH(PLC1D1)::GBP::mKate::nmy-
2UTR + unc-119(+)]; him-5 (e1490) V.
this paper NWG0047
C. elegans: NWG0053[par-6::gfp;pkc-3(ts)]:
par-6(it310[par-6::gfp]) I; pkc-3(ne4246)II
this paper NWG0053
C. elegans: OD70[mCherry::PH-PLCD1]:
unc-119(ed3) III; ltIs44[pie-1p-mCherry::
PH(PLC1D1) +unc-119(+)] V
(Kachur et al., 2008) WB Strain: OD70
C. elegans: SA131[gfp::cdc-42]: unc-
119(ed3)III; tjIs 6[Ppie-1::gfp::
cdc-42+unc-119(+)]
(Motegi and Sugimoto, 2006) WB Strain: SA131
C. elegans: TH129[gfp::par-2]: unc-119
(ed3)III;ddIs25[GFP::F58B6.3;unc-119(+)];
(Schonegg et al., 2007) TH129
C. elegans: TH159[mCherry-cdc-42]:
unc-119(ed3)III; ddls46[WRM0625bA11
GLCherry::cdc-42; Cbr-unc-119(+)]
Tony Hyman TH159
C. elegans: TH209[mCherry::par-2]:
unc-119(ed3)III; ddIs31[pie-1p::mCherry::
par-2; unc-119(+)]
(Schonegg et al., 2007) TH209
C. elegans: TY3558[gfp::his-11; b-tubulin::
gfp]: ruls[pie-1::GFPhis-11] III; ojIs1
[b-tubulin::GFP]
CGC WB Strain: TY3558
C. elegans: UE37[pie-1::gfp]: axEx73
[pie-1p::pie-1::GFP + rol-6(su1006) + N2
genomic DNA]; tubulin mCherry
Carrie Cowan UE37
C. elegans: WH423[mCherry::cdc-42(Q61L)]:
Ppie-1::mcherry::cdc-42(Q61L)
(Kumfer et al., 2010) WH423
C. elegans: WH497[gfp::chin-1]: ojls69
[pie-1::mGFP::chin-1 + unc-119(+)]
CGC WB Strain: WH497
C. elegans: WH517[gfp::wsp-1]: ojIs40
[Ppie-1::gfp::GBDwsp-1 + unc-119(+)]
CGC WB Strain: WH517
C. elegans: WM150[pkc-3(ts)]:
pkc-3(ne4246) II
(Fievet et al., 2012) WM150
C. elegans: WS5018[gfp::cdc-42]:
cdc-42(gk388); opIs295 [cdc-42p::gfp::
cdc-42(genomic)::cdc-42 3’UTR +
unc-119(+)] II.
(Neukomm et al., 2014) WB Strain: WS5018
Oligonucleotides
pkc-3(genomic) fwd:CCCACTAGTATGTCG
TCTCCGACAT (SpeI)
IDT DNA N/A
pkc-3(genomic) rev:CCCAGGCCTTCAGAC
TGAATCTTCC (StuI)
IDT DNA N/A
PH-GBP gBlock:
fwd: TTCCGTTTTCTCATTGTATTCTCTC
IDT DNA N/A
PH-GBP gBlock:
rev: ATGATGCCGGCTTAGCTAGC
IDT DNA N/A
Site-directed mutagenesis (PAM site) in pNG0018,
fwd: GTCTGTTTCGTAACTGTCTTCTGTATAACT
IDT DNA N/A
(Continued on next page)
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Site-directed mutagenesis (PAM site) in pNG0018,
fwd: TGATATCGAAACAAACACTG
IDT DNA N/A
ctl (RNAi): fwd: ATCGATAAGCTTTGTATCCTCTTG IDT DNA N/A
ctl (RNAi): rev: ACCGGCGGATCCTTAAATACGG IDT DNA N/A
Recombinant DNA
Fosmid: WRM069dD11 Source BioScience WB Clone: WRM069dD11
Plasmid: L4440 Addgene plasmid#1654
Plasmid: pUC57-C1B(codon-optimized) GenScript N/A
Plasmid: pTH699 Gift from Tony Hyman N/A
Plasmid: pC1B-Ø This paper N/A
Plasmid: pC1B-pkc-3 This paper N/A
Plasmid: CmKate2 MosSci vector Gift from Tony Hyman N/A
Plasmid: pNG0018 This paper N/A
Plasmid: pNG0019 This paper N/A
Ahringer Feeding RNAi: cdc-42 Source BioScience WB Clone: sjj_R07G3.1
Ahringer Feeding RNAi: emb-27 Source BioScience WB Clone: sjj_F10B5.6
Ahringer Feeding RNAi: par-3 Source BioScience WB Clone: sjj_F54E7.3
Ahringer Feeding RNAi: par-6 Source BioScience WB Clone: sjj_T26E3.3
Ahringer Feeding RNAi: pkc-3 Source BioScience WB Clone: sjj_F09E5.1
Ahringer Feeding RNAi: perm-1 Source BioScience WB Clone: sjj_T01H3.4
Ahringer Feeding RNAi: rga-3 Source BioScience WB Clone: sjj_K09H11.3
Ahringer Feeding RNAi: cgef-1 Source BioScience WB Clone: sjj_C14A11.3
Feeding RNAi: mlc-4 (Redemann et al., 2010) N/A
Feeding RNAi: control(ctl) This paper N/A
PH-GBP gBlock (sequence on request) IDT DNA N/A
ctl (RNAi): gBlock (sequence on request) IDT DNA N/A
Software and Algorithms
Matlab Mathworks R2016a
Kilfoil Feature Tracking (feature2D.m) http://people.umass.edu/kilfoil/
downloads.html
N/A
Fiji (ImageJ) https://fiji.sc/# N/A
ActivityBase IDBS N/ACONTACT FOR REAGENT AND RESOURCE SHARING
Requests for resources and reagents should be directed to and will be fulfilled by the Lead Contact, Josana Rodriguez
(josana.rodriguez@ncl.ac.uk). CRT0103390 may be obtained through an MTA from Cancer Research Technology (jroffey@
cancertechnology.com).
EXPERIMENTAL MODEL AND SUBJECT DETAILS
C. elegans Strains and Maintenance
C. elegans strains were maintained on nematode growth media (NGM) under standard conditions (Brenner, 1974) at 16C or 20C
unless otherwise indicated. Strains listed in the Key Resources Table. Note analysis of zygotes precludes determination of ani-
mal sex.
C. elegans Transgenic Animals
Following the scheme of (Lekomtsev et al., 2012), a codon-optimized (Redemann et al., 2011) sequence encoding the C1B domain
from human PKCa (GenScript) was inserted into pTH699 via BamHI and SmaI to generate a sfgfp::c1b fusion under control of
the pie-1 promoter and -3’ UTR (pC1B-Ø). Genomic pkc-3was amplified from fosmidWRM069dD11 (Source BioScience,WBClone:
WRM069dD11) using the following primers (fwd:cccactagtatgtcgtctccgacat; rev:cccaggccttcagactgaatcttcc) and inserted intoDevelopmental Cell 42, 400–415.e1–e9, August 21, 2017 e4
(pC1B-Ø) using SpeI and StuI to generate pC1B-pkc-3. Both plasmids were introduced by biolistic bombardment into HT1593
worms (Praitis et al., 2001), yielding NWG0012 and NWG0016.
The membrane-tethered GFP-binding protein (PH-GBP) was generated by combining amino acids 1-175 corresponding to the PH
domain of rat PH-PLCD1 (Audhya et al., 2005) and VHH4GFP (Caussinus et al., 2011) coupled by a SGQGGSGGSGGS linker. The
resulting sequence was codon-optimized (CAI = 0.49) and a single GFP intron inserted as described (Redemann et al., 2011). A syn-
thetic gBlock (IDT DNA) encoding the PH-GBP was PCR amplified and cloned in frame with a C-terminal codon-optimized mKate2
under the control of the mex-5 promoter and nmy-2 3’ UTR in a MosSCI vector containing wild-type unc-119 obtained from the
Hyman Lab. The resulting plasmid (pNG0018) was inserted at the ttTi5605mos1 site locus of DP38 worms via CRISPR after mutating
the sgRNA/PAM site following themethod described (pNG0019) (Dickinson et al., 2013). Modifiedwormswere crossed into DR466 to
generate a stable male line expressing PH-GBP (NWG0047). To rescue membrane localization of PAR-3 variants, we crossed
NWG0047 with KK1216 (par-3::gfp) or KK973 (par-3Dcr1::gfp) lines. We were unable to obtain a stable homozygous line for the
endogenously tagged PAR-3::GFP, presumably due to the toxic effects of continuously targeting all PAR-3 to the membrane
throughout embryogenesis. Thus, we used F1 progeny heterozygous for PAR-3::GFP for analysis. By contrast, for PAR-
3DCR1::GFP, which is expressed ectopically from a multi-copy random insertion, we readily obtained animals homozygous for
both PAR-3DCR1::GFP and PH-GBP, which were used for subsequent analysis. However, no significant difference in the segrega-
tion of PAR-3DCR1::GFP was seen between heterozygous and homozygous animals.
For analysis of GFP::CDC-42, SA131 was used unless otherwise indicated.
For analysis of the effects of CDC-42(Q61L) on GFP::PKC-3 localization, zygotes were taken from F1 animals resulting from
crossing KK1228 with either TH159 or WH423 due to difficulties obtaining stable animals homozygous for both markers.
Cell Lines
HEK-293 are female and were obtained from Cell Production, Cancer Research UK (CRUK) and cultivated in DMEM (Dulbecco’s
modified Eagle’s medium), 10% FBS (fetal bovine serum) and penicillin–streptomycin (Invitrogen) (Kjær et al., 2013).
Bacterial Strains
OP50 bacteria andHT115(DE3) were obtained fromCGC.DH5awas obtained fromColin Dolphin. Feeding by RNAi usedHT115(DE3)
bacteria strains containing a plasmid carrying the indicated RNAi feeding plasmid.
METHOD DETAILS
C. elegans - RNAi Culture Conditions
RNAi by feeding was performed similar to described methods (Kamath et al., 2003). Briefly, HT115(DE3) bacterial feeding clones
were inoculated from LB agar plates to LB liquid cultures and grown overnight at 37C in the presence of 10 mg/ml carbenicillin. Bac-
terial cultures were induced with 5 mM IPTG at 37 for 4h with agitation before spotting 100 ml of induced bacteria onto 60 mm agar
RNAi plates (10 mg/ml carbenicillin, 1mM IPTG). L4 larva were added to RNAi feeding plates and incubated for 24-72 hr depending on
gene and temperature. For temperature sensitive lines, feeding was performed at 15C for 48-72 hr and shifted to 25C for 2-5 hr
before imaging. For double depletion experiments, L3/L4 larva carrying par-1(zu310) or par-2(it5) temperature sensitive mutants
were placed on RNAi plates at 15C for 24 hr before a fraction of those were moved to fresh RNAi expressing plates for 18 to 22
hr at 25C. Partial RNAi formlc-4 was performed for 14-24 hr at 20C. For partial depletion of perm-1, rga-3/4 or pkc-3, bacteria ex-
pressing the desired clone were mixed at the indicated ratios with bacteria expressing control RNAi. par-3, par-6, cdc-42, pkc-3,
perm-1, rga-3/4, cgef-1 and emb-27 clones are from the Ahringer library (Kamath et al., 2003). mlc-4 is from Redemann et al.,
2010. A control RNAi clone was generated by synthesizing a random 500bp sequence using the Matlab random number generator
with no homology to the worm genome, cloned into Bgl-II / HindIII sites of L4440 (Addgene, plasmid#1654), and transformed into
HT115 bacteria.
C. elegans Embryos – Western Blots
Embryos were obtained by a standard bleaching protocol and resuspended in NuPAGE LDS sample buffer (Invitrogen) prior to son-
ication using the Biorupture (Diagenode) for 5 - 30 s on, 30 s off cycles. Samples were heated at 70C for 10min before centrifugation
at 13.000 rpm for 20 min to obtain cleared supernatant. Samples were run on a 12% NuPAGE gel using MOPS SDS running buffer
(Invitrogen) and transferred onto PVDFmembrane (Immobilon-P membrane 0.45 um, Millipore). PKC-3 and tubulin was detected us-
ing the primary (anti-PKC-3 1:10.000 and anti-tubulin 1:20.000) and secondary antibodies (as recommended by provider) indicated in
Key Resources Table and detected via chemiluminescence (ECL prime, GE Healthcare Life Sciences). PKC-3 band intensity was
analyzed using the Fiji Gel analysis tool.
C. elegans Zygotes – Drug Treatment
All drug treatment experiments were performed in 10 to 50% perm-1(RNAi) (Carvalho et al., 2011). Drugs were dissolved in DMSO
and used at the following concentrations: phorbol 12-myristate 13-acetate (PMA, Sigma-Aldrich, P1585-1MG), 100 mM; CRT90
(CRT0103390, Cancer Research Technology LTD), 10 mM. When drug treatment alone was required, we obtained zygotes with
permeable eggshells by placing L4 animals on a 1:1 mix of bacteria expressing perm-1(RNAi) and ctl (RNAi) for 16 to 20 hr ate5 Developmental Cell 42, 400–415.e1–e9, August 21, 2017
20C. When drug treatment was combined with additional RNAi treatment, L4 animals were placed on bacteria expressing
perm-1(RNAi) mixed at a 1:9 ratio with bacteria expressing the desired RNAi (par-3, par-6, cdc-42, control) and incubated for 40-
48 hr at 20C.
C. elegans Zygotes - Immunofluorescence
Immunofluorescence was performed as previously described (Andrews and Ahringer, 2007). Briefly, gravid hermaphrodite worms
were washed and then transferred to a 7 ml drop of M9 on a 0.1% poly-lysine coated well. Embryos were released using a needle
and then covered with a coverslip to compress the embryos. Slides were snap-frozen on dry ice for 30 min after which the coverslip
was quickly removed and the slide fixed in methanol at room temperature for 20 min. Samples were washed and re-hydrated with
PBS followed by two 10 min washes in PBS+0.2% Tween-20 before proceeding with antibody incubations, DAPI staining and
mounting in Mowiol (Sigma-Aldrich). All antibodies used in this study are listed in Key Resources Table. Primary antibody dilutions
used: anti-PAR-2 1:500, anti-PAR-6 1:10, anti-PKC-3 1:500 and anti-PAR-3 1:50. Secondary antibodies were used as recommended
by provider. Confocal images were acquired using Carl Zeiss Axioplan 2, LSM510Meta confocal equipped with LSM image software
and Nikon A1R equipped with Nikon elements software and a 633 objective. Cortical super-resolution images were acquired using
the DeltaVision OMX system equipped with SoftWoRx and OMX acquisition software. Secondary processing of images was per-
formed using Photoshop CS5 and Illustrator CS5 (Adobe).
C. elegans zygotes - Live Imaging
Embryos were dissected in 2-4 ml of M9 buffer (22 mM KH2PO4, 42 mM NaHPO4, 86 mM NaCl and 1 mMMgSO4) on a coverslip and
mounted under 2% agarose pads (Zipperlen et al., 2001) or dissected in Shelton’s Growth Medium (Edgar and Goldstein, 2012) and
mounted with 16-21 mm polystyrene beads between a slide and coverslip and sealed with VALAP (Goehring et al., 2011a). 16-18 mm
beads were used for cortex imaging to maximize imaging surface. In all other cases, 21 mm beads were used to minimize compres-
sion effects on development. For CRT90 experiments, embryos were dissected in the presence of 10 mMCRT90. For C1B targeting
experiments, two sides of the coverslip were left unsealed to create a flow chamber (Goehring et al., 2011a) and PMAwashed in at the
indicated times.
To maximize viability, embryos were typically imaged at 20-22C, except for temperature sensitive alleles, which were imaged at
the indicated temperatures using an objective temperature control collar (Bioptechs / Linkam, PE94). For consistency, establishment
phase embryos were taken at pronuclear meeting, and maintenance phase was defined as the interval from nuclear envelope break-
down to metaphase.
Cortex images were captured with a 100x 1.49 NA TIRF objective on a Nikon TiE (Nikon) equipped with an iLas2 TIRF unit (Roper),
488 or 561 fiber coupled diode lasers (Obis), and an Evolve Delta camera (Photometrics). Midplane imaging was performed on Carl
Zeiss Axioplan 2, LSM510 Meta confocal or a Nikon TiE with 63x or 100x objectives, further equipped with either a Spectra-X LED
light source (wide-field) or a custom X-Light V1 spinning disk system (CrestOptics, S.p.A.) with 50mm slits, 488, 561 fiber-coupled
diode lasers (Obis) and either a CoolSnap HQ or Evolve Delta (Photometrics). Imaging systemswere run usingMetamorph (Molecular
Devices) and configured by Cairn Research (Kent, UK).
In vitro PKC Enzyme Assays
The ability of compounds to inhibit the kinase activity of recombinant human baculovirus-expressed full-length PKCi was measured
using the IMAP fluorescence polarization (FP) progressive binding system (Molecular Devices #R8127, Sunnyvale, CA) in 384-well
black, non-binding, flat-bottom assay plates (Corning #3575, Corning, NY). The assay mixture (final volume = 10 mL) contained
20 mM Tris-HCL (pH 7.5), 150 mM ATP, 10 mM MgCl2, 0.01% Triton X-100, 250 mM EGTA, 1 mM DTT, 15 pM PKCi (EMD Millipore
#14-505, Billerica,MA), 100 nMFAM-PKC 3-pseudosubstrate (Molecular Devices #RP7548), 0.1%DMSOand various concentrations
of test compound. Compound dilutions (prepared in 100% DMSO) were added to the assay plate at 100 nL using the BioMek NX pin
tool (Beckman Coulter, Indianapolis, IN). Enzyme reactions were initiated by the addition of ATP (Sigma- Aldrich #A7699, St. Louis,
MO), followed by incubation of the plates for 1 hour in a 25C incubator. A 20 mL aliquot of IMAP detection reagent (1:400 in 85% 1X
Binding Buffer A and 15% 1X Binding Buffer B) was added to each well followed by a 2-hour incubation at 25C. Fluorescence po-
larization was then measured using the PerkinElmer Envision 2102 multi-label plate reader (PerkinElmer, Waltham, MA) using the FP
dual mirror, FP480 excitation filter and P-pol 535 and S-pol 535 emission filters. Data analysis was performed using ActivityBase
(IDBS, Guilford, UK). IC50 values were calculated by plotting percent inhibition versus log10 of the concentration of compound
and fitting to the 4-parameter logistic model (top and bottom constrained to 100 and 0, respectively) in XLFit 4 (IDBS).
The PKCz kinase assay was performed using the IMAP FP progressive binding system as described above for PKCi but with some
modifications. The concentration of PKCz (recombinant active protein, His tagged, expressed in Sf21 cells, Millipore, 14-525) was
10pM, while the substrate concentrations were 100 nM and 40 mM for the FAM-PKC 3-pseudosubstrate (Molecular Devices
#RP7548) and ATP, respectively.
Cellular Biochemical Assay
HEK-293 cells were transfected in a 10 cmdish as per themanufacturer’s instructions (Corning). After 16 hr, the cells were trypsinized
and seeded into a 96-well plate at 1.53104 cells/well andmediumwas replenished. After a further 24 hr, themediumwas replaced by
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ice-cold Tris lysis buffer [150mMNaCl, 20mMTris (pH 7.5), 1mMEGTA, 1mMEDTA and 1%Triton X-100]. Lysates were transferred
on to an anti-FLAG-coated ELISA plate (Sigma) and incubated for 2 hr with gentle shaking, followed by an automated wash step
(Tecan plate washer) with wash buffer [50 mM Tris (pH 7.5), 0.15 M NaCl and 0.02% Tween 20]. The immunocomplexed protein
was incubated with anti-pLLGL1/2 (S650/S654) primary antibody overnight at 4C, followed by an automated wash and then addition
of HRP-conjugated secondary antibody. After a further wash, 3,3’,5,5’-tetramethylbenzidine (Sigma) was added according to the
manufacturer’s instructions and attenuance was read at 450 nm using an Ascent plate reader (Thermo Labsystems).
Kinase Selectivity
CRT0103390was profiled using the KINOMEscan in vitro competition binding screening platform at DiscoveRx against a panel of 442
mutant and non-mutant kinases at a test concentration of 1 mM. Selectivity scores were calculated as the number of non-mutant
kinases with % activity relative to control < 20/number of non-mutant kinases tested. CRT0103390 demonstrated a high degree
of selectivity in this panel, with an S(80) of 0.09.
QUANTIFICATION AND STATISTICAL ANALYSIS
Image Analysis - General
All image analysis was performed in Fiji (ImageJ)(Schindelin et al., 2012) and Matlab (Mathworks).
Image Analysis - Asymmetry Index (ASI)
The asymmetry index (ASI) of a feature is defined by:
A P
2ðA+PÞ
where A and P define the anterior and posterior signal, respectively. Raw ASI values are normalized to the mean ASI observed in
respective controls, such that a value of 1 indicates wild-type asymmetry and zero indicates complete loss of asymmetry. Anterior
and posterior signals are defined depending on the condition examined and include cross-sectional area (AB vs P1 asymmetry), fluo-
rescence intensity on the two cell halves for themembrane (midsection PAR analysis) or cytoplasm (MEX-5, PIE-1), or cluster number
(CHIN-1).
Image Analysis – Cluster Index
The Cluster Index is defined as the variance in cortical intensity within the anterior domain. It was calculated in Matlab across user
specified ROIs that were subject to background subtraction and normalization to mean intensity before analysis.
Image Analysis – CHIN-1 Foci
CHIN-1 foci were identified using the feature2D.m script, part of the feature detection and particle tracking package from the Kilfoil
Lab (Pelletier et al., 2009). Embryos were automatically detected and partitioned into 3 domains (Anterior, Middle, Posterior) and
normalized anterior vs posterior particle densities used for ASI calculation.
Image Analysis – MEX-5 Mobility
For MEX-5 mobility, five pre-bleach frames were captured by spinning disk confocal microscopy. A central 20-pixel wide stripe was
then bleached along the AP axis using a 473 diode laser (Obis) and recovery was monitored every 2 s. Because MEX-5 is uniform in
the quantified conditions, fluorescence was monitored within a central 20 x 100-pixel box.
Image Analysis - Colocalization
Colocalization analysis of PAR-6 and PAR-3 was performed in ROIs at the anterior cortex of establishment phase zygotes (wild-type
n=8 and pkc-3(ts) n=9). Costes’ Mask and intensity correlation quotient (Li et al., 2004) were obtained using JaCOP plug-in in Fiji.
Image Analysis – Flow Speeds
Anterior-directed cortical flow speed during establishment phase was measured using midplane, brightfield images acquired every
second until late establishment phase at which point we switched to fluorescent imaging to obtain suitable images formeasuring PAR
asymmetry. Using the Kymograph Plugin in Fiji (Seitz and Surrey, 2006), we generated kymographs for individual embryos by tracing
a segmented line along the cortex starting at the origin of flow. A minimum of 10 yolk granule trajectories, each spanning approxi-
mately 200s were selected for a minimum of 5 embryos per condition. The cortical flow velocity was defined as the total distance
over time calculated from a line connecting the start and end positions of the granule on the kymograph. Measurement of cortical
flow in wild-type embryos expressing GFP fusions to PAR-3, PKC-3 or CDC-42 yielded a velocity of 7.1+/-1.4 mm/min (n=22), consis-
tent with previously published values (7.66+/-1.0 mm/min, n=6)(Munro et al., 2004).e7 Developmental Cell 42, 400–415.e1–e9, August 21, 2017
Image Analysis – Anterior Cortical Intensity (Immunofluorescence)
Anterior cortical intensity of each PAR protein is the mean greyscale value of a line 2 pixels wide (in each corresponding fluorescent
channel) covering the PAR-3 cortical domain of the zygote. The cortical intensity value is then normalized by dividing it by the mean
greyscale value of a nearby cytoplasmic region to correct for embryo IF staining variability. In par-3(RNAi) zygotes, we cannot distin-
guish anterior from posterior cortex and the entire cortex of zygotes is analyzed. Each experimental condition was analyzed in three
independent experiments.
Image Analysis – Anterior PAR Retraction (Immunofluorescence)
The posterior boundary of anterior PARs in fixed, midsection fluorescent images is defined at the intersection between the equatorial
zygote line (longest line linking the zygotes’ poles) and the line that links the cortical ends (top and bottom) of the PAR protein
analyzed. Retraction is the distance between this posterior boundary and the posterior pole of the zygote. Retraction difference is
defined as the difference in retraction distance between PAR-3 and PKC-3. Data were collected from three independent
experiments.
Image Analysis – Intensity Profile Extraction
In general, to assess PAR signal frommidsection images, a 60-pixel wide stripe encompassing the cell membrane was extracted and
straightened to generate a profile for each embryo for further analysis.
For spatial analysis (ASI, profile plots, domain size, segregation efficiency), the top 4 central pixels corresponding to themembrane
were taken at each x-position and averaged to the given local membrane signal. Background and cytoplasmic signal were calculated
locally from inner and outer edges of this stripe, allowing normalization for variation in signal between conditions. Briefly, background
was subtracted and then membrane divided by cytoplasmic intensity.
Image Analysis – PAR-3 versus PKC-3 Cortical Profile Comparison (Immunofluorescence)
To quantitatively compare PAR cortical profiles in multi-labelled fixed embryos, two identical profiles along the cortex were extracted
in each channel as above. Each set of profiles was split in half to generate two boundary regions. After normalization tomaximum and
minimum values, profiles were registered using the inflection point, c, based on fitting each PAR-3 profile using the following function:
IðxÞ= a+b
2
ðerfðmx  cÞÞ
where erf is the error function, c is the domain boundary position, m the boundary slope and a and b allow for scaling and displace-
ment on the y-axis.
Image Analysis – Domain Size/Segregation Efficiency
To extract domain size data (PAR-2 domain size change, segregation efficiency) from single channel images, cortical fluorescence
profiles were normalized to total embryo perimeter length and aligned to the center of posterior PAR domain determined by fitting the
profile to the following function:
IðxÞ= a±b
2
ðerfðmx  c1Þ  erfðmx  c2ÞÞ
with the center of the posterior domain specified by:
c2  c1
2
posterior domain size given by:
c2  c1
L
and anterior domain size given by:
1 c2  c1
L
where L is the length of the profile.
PAR-2 domain size change for each embryo was calculated as the ratio of domain size taken from images before and 5 min after
PMA addition. Segregation efficiency into the anterior was scored by relative anterior domain size, with smaller anterior domains
defined as more efficient segregation.
Image Analysis – Total Membrane Signal Change
To estimate total membrane signal in PAR-6 and PKC-3 rescue experiments straightened profiles were projected in x to give a cross-
section profile spanning background, crossing the membrane and into the cytoplasm for the full circumference. Cross-section pro-
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we generated a mean cross-section for embryos with no detectable membrane signal from par-3 and par-6 RNAi embryos to define
the shape of the outside to inside fluorescence step. The shape of this curve was extremely consistent allowing a mean profile to be
generated, which could then be subtracted from individual embryo cross-section profiles with the sum of the difference taken as
membrane signal.
For PAR-2 retention in C1B-induced PKC-3membrane-targeting experiments, a cytoplasm-normalized 4-pixel wide stripe encom-
passing the cell membrane was taken from images before and 5 min after PMA addition to generate profiles. PAR-2 retention was
defined as the ratio of total membrane signal before and after PMA addition.
Statistics
For all assays, significance was assessed using an unpaired, two-tail Student’s T test unless otherwise noted with the following
criteria: *p<0.05, **p<0.01, ***p<0.001, ****p<0.0001. Data are presented as mean values plus all data points or mean ± 95% confi-
dence interval (CI), in which case (N) is indicated.
Data and Software Availability
Sequence data for pkc-3(ne4246) has been submitted to Wormbase (WB Gene: pkc-3).e9 Developmental Cell 42, 400–415.e1–e9, August 21, 2017
